Abstract-The isolation and characterization of a plasma membrane preparation from rat heart is described. Enzymatic, chemical, and electron microscopic analysis revealed a relative lack of contamination with nuclear, mitochondrial, ribosomal, and sarcoplasmic reticulum membrane. One calcium binding site (I& = 265 pM, B,,, = 65 nmoIes/mg protein) was detected by equilibrium diaiysis. Monovalent metal ions exhibited ItSlOO-fold less inhibition potency than divalent metal ions when analyzed by competitive inhibition of calcium binding. The range of K, values found for divalent metal ions was similar to the K, value for calcium. La+3 produced a potent non-competitive inhibition, A large variety of structural analogues of d,l-propranolol, many of which have been shown to lack B-adrenergic blocking activity, were competitive inhibitors of the calcium binding activity, with Ki values ranging from 40-W pM. Electrophilic, hydrophobic, and diamino substituents greatly increased the inhibitory activity. There was no significant difference between related tertiary and quaternary amines. The experimental antiarrhythmic agent UM 272 had the least ability to inhibit calcium binding to the cardiac plasma membrane preparation (Ki = 795 PM). However, UM 424, another experimental antiarrhythmic agent, had an inhibitory activity similar to df-propranolol (Ki = 115pM and 108pM, respectively),
There has been a considerable amount of speculation about the identity and location of the intracellular membrane storage sites which serve to release large amounts of calcium into the cytoplasm immediately after the depolarization of the cardiac plasma membrane (sarcolemma). G. A. Langer [l, 21 has postulated that subsarcolemma stores of calcium serve as the rapid release sites which contribute to the pool of "contractile dependent" calcium. This intermediate region of calcium binding sites, which may include the external lamina and T tubule membrane systems, would be in rapid equilibrium with the pool of extracellular calcium. Calcium release could be triggered by the increased influx of extracellular sodium or calcium ions which occurs during and immediately after the membrane depolarization event. Calcium would be transferred into the cytoplasm, to activate myofibril contraction, by a proposed el~troneutral calcium exchange process.
The proposed role of the cardiac plasma membrane as an ion exchange region of the cell has received additional attention in pharmacological research designed to determine the mechanism of action of membrane active drugs, including local anesthetics, /I-adrenergic antagonists and antiarrhythmic agents [3] . Local anesthetic agents interfere with membrane depolarization by displacement of calcium from * This work was supported by the Medical Research Service of the Veterans Administration and by Grant HLI5766 from the National Heart and Lung Institute.
anionic binding sites on the cell membrane [4] . j?-Adrenergic antagonists, such as ~I-propranolol, have been found to significantly decrease calcium accumulation into sarcoplasmic reticulum [S] . The ability of antiarrhythmic agents to prolong the atrioventricular electrical conduction time and prolong the effective refractory period may be related to decreases in sodium and potassium conductance across the plasma membrane . The effects of these compounds on calcium conductance are unknown. Madeira et al. [9] have previously demonstrated the ability of selected local anesthetic agents to competitively inhibit calcium binding to rabbit skeletal muscle plasma membrane. However, a critical evaluation and comparison of the ability of the various types of membrane-active organic amines, to inhibit calcium binding to purified preparations of cardiac plasma membrane, has not been previously presented. Furthermore, the recent development of a new category of antiarrhythmic agents by Lucchesi and coworkers [6-S] , which do not exhibit local anesthetic or /I-adrenergic antagonist activity, provide a unique opportunity to determine if the action of these compounds includes a direct effect on calcium ion metabolism in cardiac plasma membrane. This communication will describe the isolation of a preparation of rat heart plasma membrane, using relatively mild, low ionic strength buffer conditions. A comparison of the ability of a wide variety of structural analogues of di-propranolol to inhibit the calcium binding activity of the plasma membrane preparation will be presented. Isolation of plasma membranes. The method for isolation of rat heart plasma membranes were based on procedures described by Carvalho et ~71. [lo], Rosenthal et al. [ll] and 131 . Freshly excised rat (female) hearts were rinsed and minced in homogenization buffer containing 50mM CaC12, 1OmM histidine-Tris-HCl at pH 7.6. The tissue was homogenized for 45sec in a Br~nkmann Polytron (PCV-2) set at speed 4.5. The homogenate w&s filtered through a stainless steel screen (406 micron mesh). and the filtrate was allowed to stand for 1 hr at 4'. The mixture was centrifuged for 1 min at 272 9.
The pellet was resuspended in l0mM histidine-Tris-HCI pH 7.6 with a motor driven teflon homogenizer and centrifuged as before. This process was repeated until the supernatant solution was colorless and free from protein. The membranes were resuspended in ice cold deionized water that was neutralized to pH 7.8 with a few grains of Tris. After 30min at 4' the membranes were collected by centrifugation for 5 min at 272~. The water treatment was repeated once. In some cases. the preparation was exposed to IOmM histidine-Tris-HCI pH 7.6 containing 1.2 M KC1 for 10 min at 4'. The membranes were collected by centrifugation at lO.OOOg for 30 min and resuspended in 1OmM histidine-Tris-HCI pH 7.6 containing 0.25 M sucrose. The membrane suspension was layered on top of a discontinuous sucrose gradient containing equal volumes of 0.3 M/l.32 M/1.7.5 M sucrose. After centrifugation for 2 hr at 76,400~ (Beckman SW 41 rotor), the plasma membrane fraction was collected at the 1.32 M/l.75 M interface. The membranes were washed once and resuspended in 1OmM histidineTris-HCI pH 7.6 containing 0.25 M sucrose. Individual 0.5-1.0 ml aliquots (5-10 mg protein/ml) were stored at -4o-' for periods up to 2 months.
Getteral methods. Protein concentration was determined by the method of Lowry et al. [14] with bovine serum albumin as the reference standard. DNA was determined by the method of Richards [l5] 'inhibitor to prevent calcium binding, the agent was added to the CaCl, side of the dialysis chamber at a final concentration of O.l-l.OmM. In all cases, the final volume of each dialysis chamber was 0.6 ml. The two halves of the dialysis block were separated by a single sheet of cellulose dialysis membrane (5 x 5 cm; Be1 Art No. 299). previously soaked overnight in deionized water. Dialysis was performed by vertical rotation for 24 hr at 4-at a constant speed of 10 RPM (Scientific Industries Rotator, Model 150). Duplicate aliquots of lOO$ were removed from each half chamber with a lOO$ Eppendorf pipet and the amount of radioactivity was measured by liquid scintillation.
Control experiments revealed that calcium equilibrium was estadlished after 20 hr at 4 '. Equivalent binding results could be obtained if 45Ca was initially added to either half of a dialysis chamber. The average variance from true equilibrium was 4.8 per cent. In order to minimize the effect of this variability, the total concentration of protein and calcium were arranged so that the amount of calcium bound was Z-25 per cent of the total calcium con~ntration.
Calcium binding constants were determined according to Klotz et al. [22] buffer and overnight storage in buffer containing 0.2 M sucrose, the pellets were post-fixed in phosphate buffer containing l"/ Osmium tetroxide for 1 br and then stained with 0.5% uran)l acetate according to Karnovsky [24] . The stained pellets were dehydrated and embedded in Epon as described by Luft [25] . Sections of 700A thickness were cut on a Porter-Blum (MT IIB) microtome and stained with uranyl acetate according to Venable and Coggeshall [26] . The sections were examined in a Hitachi IIC electron microscope operated at 75 KV. 
RESULTS

Properties of
Measurement of calcium binding
Equilibrium dialysis was used to determine the extent of calcium binding to the plasma membrane preparation.
In the calcium concentration range normally employed in these studies , only one type of calcium binding site could be detected (Fig. 3) [30] indicated that the binding capacity for calcium was 2.4 times greater than the binding capacity of plasma membrane prepared in the absence of KCl. However, the I(, values were similar in both preparations.
Thus, the KC1 treatment apparently removes protein material which does not significantly contribute to the calcium binding of the plasma membrane.
Inhibition of calcium binding by other metal ions
All of the divalent metal ions produced a competitive inhibition within a concentration range The results of experiments designed to measure the ability of a series of structural analogues of DL-propranolol to inhibit the calcium binding activity Table 2 . The results are organized in an attempt to facilitate comparisons of the effects of a related group of drug structures, differing by substitutions at a single position. The quaternary nitrogen derivative of propranolol, UM 272, is much less inhibitory than propranolol.
However, UM 282, which differs from UM 272 by a phenyl group substitution, is more inhibitory than propranolol.
The results of studies with compounds listed in Series II, demonstrate that a potent competitive inhibition of calcium binding can be achieved with a quaternary amine when the phenoxyl group is substituted with a phenyl group or iodine. Relatively less inhibition was produced by the methyl or hydrogen substituted analogues. The results of compounds listed in series III demonstrate that a tertiary substituted nitrogen atom (UM 329) is equivalent to a quaternary substituted nitrogen atom (UM 301) when calcium inhibition activities are compared. A nitrogen atom with a lower degree of substitution will produce less inhibition. compound provides an interesting prototype for the design of future membrane active agents. The concentrations required to produce a significant inhibition of calcium binding to the plasma membrane preparation fall within the approximate range of 100-4OO~M. These concentrations may be higher than would be required to achieve inhibition in uivo especially since the local concentration of a drug at membrane binding sites may be much higher than that in free circulation [8, 39, 40] . In fact, Kniffen et ai. [8] have observed that there is a poor correlation between the plasma concentration and the therapeutic effectiveness of quaternary ammonium antiarrhythmic agents, because myocardial tissue appears to concentrate these compounds. Thus, while the con~ntratio~ required to achieve inhibition of calcium binding as determined in these studies may serve as a relative indication of the inhibition potency, the-results do not indicate the thera~utic dose which would be required to elicit this effect in uiuo.
We have shown that DL-propranolol. UM 212, and UM 424 have widely differing abilities to competitively inhibit the calcium binding activity of the plasma membrane preparation. B. R. Lucchesi and coworkers have presented a series of communications C4-81 which describe the antiarrhythmic properties of these compounds. When DL-propranolol, UM 272. and UM 424 were used to reverse ouabain-induced arrhythmia in live dogs, an average dose of 6.1, 3.0, and 4.6mg drug/kg body weight (respectively) was required to restore and maintain a nor&al sinus rhythm for a period of at feast 30min. In comparison, the corresponding Ki values for inhibition of calcium binding, as determined in the present study, are 108, 795 and 115 PM. Thus, the most potent antiarrhythmi~ agent (UM 272) has the least ability to inhibit calcium binding to cardiac plasma membrane. This low activity for competitive inhibition may be another desirable characteristic of this agent. in addition to the previously described [7] lack of anesthetic and fi-adrenergic blocking activities. The relative inability of an antiarrhythmic agent to inhibit calcium binding would avoid the undesirable side-effects (depression of myocardial contractility) encountered with some antiarrhythmic agents [39] .
